222

SHANGHAI MICROPORT MEDBOT (GROUP) C

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪12.10 B‬HKD
−1.16HKD
‪−1.12 B‬HKD
‪115.57 M‬HKD
‪230.09 M‬
Beta (1Y)
1.85

About SHANGHAI MICROPORT MEDBOT (GROUP) C

Headquarters
Shanghai
Employees (FY)
650
Founded
2015
ISIN
CNE100004QP1
FIGI
BBG011DL0RD1
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. Its product portfolio covers surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice, and percutaneous surgical procedures. Its products include Toumai, DFVision, and SkyWalker. The company was founded on May 11, 2015 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 2252 is 13.30 HKD — it has increased by 3.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI MICROPORT MEDBOT (GROUP) C stocks are traded under the ticker 2252.
SHANGHAI MICROPORT MEDBOT (GROUP) C is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
2252 stock is 5.17% volatile and has beta coefficient of 1.85. Check out the list of the most volatile stocks — is SHANGHAI MICROPORT MEDBOT (GROUP) C there?
Yes, you can track SHANGHAI MICROPORT MEDBOT (GROUP) C financials in yearly and quarterly reports right on TradingView.
2252 stock has risen by 13.29% compared to the previous week, the month change is a 5.81% fall, over the last year SHANGHAI MICROPORT MEDBOT (GROUP) C has showed a 41.79% decrease.
2252 net income for the last quarter is ‪−511.17 M‬ HKD, while the quarter before that showed ‪−609.60 M‬ HKD of net income which accounts for 16.15% change. Track more SHANGHAI MICROPORT MEDBOT (GROUP) C financial stats to get the full picture.
Today SHANGHAI MICROPORT MEDBOT (GROUP) C has the market capitalization of ‪12.37 B‬, it has increased by 2.91% over the last week.
No, 2252 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2252 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI MICROPORT MEDBOT (GROUP) C stock right from TradingView charts — choose your broker and connect to your account.
2252 reached its all-time high on Nov 16, 2021 with the price of 73.44 HKD, and its all-time low was 9.68 HKD and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 650.00 employees. See our rating of the largest employees — is SHANGHAI MICROPORT MEDBOT (GROUP) C on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI MICROPORT MEDBOT (GROUP) C technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI MICROPORT MEDBOT (GROUP) C stock shows the sell signal. See more of SHANGHAI MICROPORT MEDBOT (GROUP) C technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on SHANGHAI MICROPORT MEDBOT (GROUP) C future price: according to them, 2252 price has a max estimate of 35.02 HKD and a min estimate of 15.12 HKD. Read a more detailed SHANGHAI MICROPORT MEDBOT (GROUP) C forecast: see what analysts think of SHANGHAI MICROPORT MEDBOT (GROUP) C and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHANGHAI MICROPORT MEDBOT (GROUP) C EBITDA is ‪−894.29 M‬ HKD, and current EBITDA margin is −772.06%. See more stats in SHANGHAI MICROPORT MEDBOT (GROUP) C financial statements.